Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

NCT03862430

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Center for Neurosciences Tucson, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • UC Irvine Health- Chao Family Comprehensive Cancer Center Orange, California, United States
  • Providence St. John's Cancer Institute Santa Monica, California, United States
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients

NCT06540391

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centre Georges Francois Leclerc Dijon, France
  • CHU de Lille - Hopital Claude Huriez Lille, France
  • Centre Leon Berard Lyon, France
  • AP-HM - Hopital de la Timone Marseille, France
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

NCT04674683

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
  • Emad Ibrahim, MD, INC Redlands, California, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

NCT05933577

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Highlands Oncology Group ( Site 1943) Springdale, Arkansas, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1918) Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay ( Site 1929) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1933) New Haven, Connecticut, United States
View all 165 locations
View Trial Details

Related conditions